Evaluating the Effectiveness of Platelet Rich Plasma Therapy in Enhancing Endometrial Receptivity for Women with Infertility: A Narrative Review
- PMID: 40510957
- PMCID: PMC12156758
- DOI: 10.4103/jpbs.jpbs_1876_24
Evaluating the Effectiveness of Platelet Rich Plasma Therapy in Enhancing Endometrial Receptivity for Women with Infertility: A Narrative Review
Abstract
Infertility is a condition that affects a significant percentage of couples globally, affecting their social and psychological well-being. It disrupts many aspects of life, influencing individuals' social and psychological experiences. The primary causes of infertility are diverse and include endogenous factors, various psychological variables, congenital or acquired disorders in females, and genetic and hormonal issues in males. In females, implantation failure is a key obstacle to successful embryo implantation, with poor endometrial receptivity being a major contributing factor. Several methods have been explored to enhance endometrial thickness and improve implantation success rates. These include treatments such as granulocyte-colony stimulating factor, low-dose acetylsalicylic acid, vaginal sildenafil, and estrogens. Among these, platelet-rich plasma (PRP) has emerged as a promising approach. PRP, derived from the patient's own blood, is rich in growth factors such as platelet-derived growth factor (PDGF), transforming growth factor (TGF), epidermal growth factor (EGF), and vascular endothelial growth factor (VEGF). These factors are crucial in promoting cell replication and tissue regeneration. PRP therapy has shown significant potential in enhancing endometrial proliferation and improving pregnancy rates, particularly in patients with thin endometrium and those with a history of recurrent implantation failure. Numerous studies have reported that intrauterine PRP treatment leads to increased endometrial thickness and better clinical pregnancy outcomes. The PRP is obtained through a centrifugation process that separates platelet-rich plasma from red blood cells. This PRP is then injected into the endometrial cavity, typically midcycle, to boost endometrial receptivity. Systematic reviews have consistently highlighted the positive effects of PRP treatment on pregnancy outcomes in women with thin endometrium, offering hope to those facing challenges with implantation and fertility. PRP therapy represents a promising advancement in reproductive medicine, providing an effective option for improving endometrial receptivity and achieving successful pregnancies.
Keywords: Endometrium thickness (ET); infertility; platelet-rich plasma (PRP); pregnancy.
Copyright: © 2025 Journal of Pharmacy and Bioallied Sciences.
Conflict of interest statement
There are no conflicts of interest.
Similar articles
-
The Effect of Autologous Platelet Rich Plasma on Endometrial Receptivity: A Narrative Review.Medicina (Kaunas). 2025 Jan 15;61(1):134. doi: 10.3390/medicina61010134. Medicina (Kaunas). 2025. PMID: 39859116 Free PMC article. Review.
-
An update on platelet-rich plasma (PRP) therapy in endometrium and ovary related infertilities: clinical and molecular aspects.Syst Biol Reprod Med. 2021 Jun;67(3):177-188. doi: 10.1080/19396368.2020.1862357. Epub 2021 Feb 25. Syst Biol Reprod Med. 2021. PMID: 33632047 Review.
-
Injectable antioxidant hyaluronan/chitosan hydrogel as a platelet-rich plasma and stem cell carrier to promote endometrial regeneration and fertility restoration.Acta Biomater. 2025 Mar 15;195:201-215. doi: 10.1016/j.actbio.2025.01.062. Epub 2025 Jan 31. Acta Biomater. 2025. PMID: 39894327
-
Study Protocol: Evaluating the Effect of Autologous Platelet-Rich Plasma Infusion in the Endometrial Cavity for Enhanced Embryo-Endometrium Synchrony in Patients with Repeated Implantation Failure.J Pharm Bioallied Sci. 2025 May;17(Suppl 1):S897-S900. doi: 10.4103/jpbs.jpbs_260_25. Epub 2025 Apr 21. J Pharm Bioallied Sci. 2025. PMID: 40510993 Free PMC article.
-
Angiogenic factor-driven improvement of refractory thin endometrium with autologous platelet-rich plasma intrauterine infusion in frozen embryo transfer cycles.Front Endocrinol (Lausanne). 2024 Sep 3;15:1431453. doi: 10.3389/fendo.2024.1431453. eCollection 2024. Front Endocrinol (Lausanne). 2024. PMID: 39290323 Free PMC article.
References
-
- Zargar M, Pourjafar Z, Salemi S, Barati M. Evaluation of the consequences of double ovarian stimulation through shanghai protocol in patients with poor ovarian respond. In Review. 2022. [[Last accessed on 2024 Feb 5]]. Feb. Available from: https://www.researchsquare.com/article/rs-1283105/v1 .
Publication types
LinkOut - more resources
Full Text Sources
Research Materials